Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesBoston Scientific Announces Schedule for European Society of Cardiology Congress
Boston Scientific, 08/28/09
Boston Scientific Corporation announced the schedule of the Company's major events and news announcements for the European Society of Cardiology Congress, which runs from August to September 2 in Barcelona. Highlights include final results from the MADIT–CRT trial and two–year results from the SYNTAX trial.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Milatuzumab – a promising new immunotherapeutic agent
Expert Opinion on Investigational Drugs, 12/17/09
Association of trial registration with the results and conclusions of published trials of new oncology drugs
Trials, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor